These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 15344592)

  • 1. Vascular involvement in systemic sclerosis (SSc).
    Kahaleh MB
    Clin Exp Rheumatol; 2004; 22(3 Suppl 33):S19-23. PubMed ID: 15344592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular disease in scleroderma: mechanisms of vascular injury.
    Kahaleh B
    Rheum Dis Clin North Am; 2008 Feb; 34(1):57-71; vi. PubMed ID: 18329532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of vascular endothelial function using the oral endothelin receptor antagonist bosentan in patients with systemic sclerosis.
    Sfikakis PP; Papamichael C; Stamatelopoulos KS; Tousoulis D; Fragiadaki KG; Katsichti P; Stefanadis C; Mavrikakis M
    Arthritis Rheum; 2007 Jun; 56(6):1985-93. PubMed ID: 17530638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin-mediated cellular events in pulmonary fibrosis associated with systemic sclerosis (scleroderma).
    Ludwicka-Bradley A; Bogatkevich G; Silver RM
    Clin Exp Rheumatol; 2004; 22(3 Suppl 33):S38-46. PubMed ID: 15344597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microvascular damage in systemic sclerosis: detection and monitoring with biomarkers.
    Hummers LK
    Curr Rheumatol Rep; 2006 Apr; 8(2):131-7. PubMed ID: 16569372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis.
    Andreucci E; Margheri F; Peppicelli S; Bianchini F; Ruzzolini J; Laurenzana A; Fibbi G; Bruni C; Bellando-Randone S; Guiducci S; Romano E; Manetti M; Matucci-Cerinic M; Calorini L
    Rheumatology (Oxford); 2021 Oct; 60(10):4508-4519. PubMed ID: 33471123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved endothelial function after endothelin receptor blockade in patients with systemic sclerosis.
    Cardillo C; Schinzari F; Melina D; Mores N; Bosello S; Peluso G; Zoli A; Ferraccioli G
    Arthritis Rheum; 2009 Jun; 60(6):1840-4. PubMed ID: 19479828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis.
    Del Papa N; Colombo G; Fracchiolla N; Moronetti LM; Ingegnoli F; Maglione W; Comina DP; Vitali C; Fantini F; Cortelezzi A
    Arthritis Rheum; 2004 Apr; 50(4):1296-304. PubMed ID: 15077314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased serum IL-33 levels may indicate vascular involvement in systemic sclerosis.
    Terras S; Opitz E; Moritz RK; Höxtermann S; Gambichler T; Kreuter A
    Ann Rheum Dis; 2013 Jan; 72(1):144-5. PubMed ID: 22858587
    [No Abstract]   [Full Text] [Related]  

  • 10. Is there evidence for vasculitis in systemic sclerosis?
    Saketkoo LA; Distler O
    Curr Rheumatol Rep; 2012 Dec; 14(6):516-25. PubMed ID: 23065452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated levels of pentraxin 3 in systemic sclerosis: associations with vascular manifestations and defective vasculogenesis.
    Shirai Y; Okazaki Y; Inoue Y; Tamura Y; Yasuoka H; Takeuchi T; Kuwana M
    Arthritis Rheumatol; 2015 Feb; 67(2):498-507. PubMed ID: 25385504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular disease in scleroderma. Endothelial T lymphocyte-fibroblast interactions.
    Kahaleh MB
    Rheum Dis Clin North Am; 1990 Feb; 16(1):53-73. PubMed ID: 2406811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of vascular disease biomarkers for digital ulcers in systemic sclerosis patients.
    Silva I; Teixeira A; Oliveira J; Almeida I; Almeida R; Vasconcelos C
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S127-30. PubMed ID: 26242908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial dysfunction in systemic sclerosis.
    Altorok N; Wang Y; Kahaleh B
    Curr Opin Rheumatol; 2014 Nov; 26(6):615-20. PubMed ID: 25191994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive investigation of disease-specific short peptides in sera from patients with systemic sclerosis: complement C3f-des-arginine, detected predominantly in systemic sclerosis sera, enhances proliferation of vascular endothelial cells.
    Xiang Y; Matsui T; Matsuo K; Shimada K; Tohma S; Nakamura H; Masuko K; Yudoh K; Nishioka K; Kato T
    Arthritis Rheum; 2007 Jun; 56(6):2018-30. PubMed ID: 17530642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of endothelin-1 signaling in the fibrosis observed in systemic sclerosis.
    Leask A
    Pharmacol Res; 2011 Jun; 63(6):502-3. PubMed ID: 21315153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic sclerosis. A vascular perspective.
    LeRoy EC
    Rheum Dis Clin North Am; 1996 Nov; 22(4):675-94. PubMed ID: 8923590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet activation, endothelial cell dysfunction in the absence of anticardiolipin antibodies in systemic sclerosis.
    Lima J; Fonollosa V; Fernández-Cortijo J; Ordi J; Cuenca R; Khamashta MA; Vilardell M; Simeón CP; Picó M
    J Rheumatol; 1991 Dec; 18(12):1833-6. PubMed ID: 1839040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular disease in scleroderma: angiogenesis and vascular repair.
    Mulligan-Kehoe MJ; Simons M
    Rheum Dis Clin North Am; 2008 Feb; 34(1):73-9; vi. PubMed ID: 18329533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A possible contribution of lipocalin-2 to the development of dermal fibrosis, pulmonary vascular involvement and renal dysfunction in systemic sclerosis.
    Takahashi T; Asano Y; Noda S; Aozasa N; Akamata K; Taniguchi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Tada Y; Sugaya M; Kadono T; Sato S
    Br J Dermatol; 2015 Sep; 173(3):681-9. PubMed ID: 25781362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.